“The Week”: Turnaround

• 

  François Bloch
  Experte

Switzerland

The shares of Winterthur-based Sulzer AG (ticker symbol: SUN SW) have performed really strongly, with the share price up +12.6 % since the turn of the year 2024/2025. If my quantitative models prove correct, the operating result (EBIT) could improve from CHF 111.4 million to CHF 518.83 million in the period from 2022 to 2027, which would be a clear exclamation mark for the CHF 4.98 billion stock.
Trading strategy: Buy

With a share price increase of 48.55% since the beginning of 2025, the Zug-based dermatology specialist Galderma (ticker symbol: GALD SW) is becoming a major success story on the Swiss stock exchange. The operating result (EBIT) could rise from USD 738 million to USD 1.766 billion between 2024 and 2027. The EBIT margin could reach a peak of 23.84% in 2027.
Trading strategy: Reloading

Towards the end of the year, the securities of the Bank Julius Baer (ticker symbol: BAER SW) had a positive stock market performance. The operating result (EBIT) is likely to rise from CHF 1.313 billion to CHF 1.396 billion in the period from 2022 to 2027, which means that a price/earnings ratio of less than 11.3 points would once again be possible in 2027. It could also make sense to consistently reinvest the dividend in new securities on an annual basis.
Trading strategy: Buy

Largely under the radar of the major market players, the shares of Belimo Holding (ticker symbol: BEAN SW), which in my view is a considerable mistake. If my model expectations are reflected in reality, the operating result (EBIT) could rise from CHF 152.4 million to CHF 321 million between 2022 and 2027. The decisive factor here would be to reinvest the dividend annually in new shares.
Trading strategy: Buy

The plants of former ABB subsidiary Accelleron Industries (ticker symbol: ACLN SW) have developed into a top-class stock market with a price increase of +36.40% in 2025 alone. If the extrapolated trend continues, the operating result (EBIT) could rise from USD 157 million to USD 366.5 million between 2022 and 2027, which would be extremely promising for the CHF 5.98 billion stock. The dividend per share should also increase from CHF 0.73 to CHF 2.076 over the same period.
Trading strategy: Buy

Europe

The shares of the Austrian Raiffeisenbank International (ticker symbol: RBI AT) are in excellent shape with a price increase of +87.85% since the turn of the year 2024/2025. My models suggest that the book value per share could increase from EUR 53.7 to EUR 63.18 in the period from 2022 to 2027. The expected dividend yield as of 2027 would be 5.13%, which would be considered more than excellent.
Trading strategy: Buy

I am fascinated by the shares of the Irish airline Ryanair (ticker symbol: RYA LN), which have not yet been sufficiently taken into account by many market participants. If the forecasts can be realized, the operating result (EBIT) could rise from EUR 1,573 billion to EUR 2,896 billion between 2023 and 2028. With an expected dividend yield of 2.07% in 2028, the overall picture would appear consistent. It would also be important here to reinvest the distributions in new securities on an annual basis.
Trading strategy: Buy

For the first time in 2025, the French company Aéroports de Paris (ticker symbol: ADP FP) with a price increase of +17.99%, which is extremely strong compared to the index. The operating result (EBIT) could improve from EUR 988 million to EUR 1.516 billion between 2022 and 2027, which should certainly generate enthusiasm. Particularly noteworthy would be the forecast record EBIT margin of 20.92% in 2027, which could be considered sensational in a European industry comparison.
Trading strategy: Buy

I find the business segment of the French technology group Thales (ticker symbol: HO FP). The operating result (EBIT) is expected to increase from EUR 1,935 billion to EUR 3,312 billion in the period from 2022 to 2027. Here, too, it could make sense to consistently reinvest the dividend in new securities on an annual basis. One thing in particular would be crucial for full investment success: patience.
Trading strategy: Buy

I find the Spanish insurance title fascinating Mapfre (ticker symbol: MAP SM), and there is currently no end in sight to its positive development. The book value per share could rise from EUR 2.36 to EUR 3.38 between 2022 and 2027, which would be classified as strong by definition. In addition, the expected dividend yield in 2027 is likely to reach a new record high of 5.64%.
Trading strategy: Buy

The Swedish Swedbank AB (ticker symbol: SWED A) promises considerable potential for the coming years in my view. The operating result (EBIT) could improve from SEK 31.806 billion to SEK 44.016 billion between 2022 and 2027. Particularly noteworthy would be the expected record EBIT margin of 61.8% by 2027, which is likely to attract new interest from investors.
Trading strategy: Buy

The Italian company offers enormous potential for years to come Poste Italiane S.P.A (ticker symbol: PST IM), in particular due to the very attractive dividend distributions. If the forecasts are confirmed, the operating result (EBIT) could rise from EUR 2,291 billion to EUR 3,521 billion between 2022 and 2027. The expected dividend yield in 2027 would be 6.56%, whereby it would also make sense to consistently reinvest the distributions on an annual basis.
Trading strategy: Buy

USA

For growth-oriented investors, it is important to focus on the map of Newmont (ticker symbol: NEM US): The operating result (EBIT) of the commodity value could improve from USD 203 million to an incredible USD 12.949 billion between 2022 and 2027. The book value per share could increase in the same period from USD 24.41 to USD 45.09.
Trading strategy: Buy

I find the technology stock ATI (ticker symbol: ATI US) extremely exciting: the company is showing real power in the truest sense of the word! The operating result (EBIT) could rise from USD 480.9 million to USD 903.5 million between 2022 and 2027. Only the dividend payout is at low ebb.
Trading strategy: Buy

In the current market environment, the shares of the Finnish sporting goods manufacturer Amer Sports Inc. (ticker symbol: AS US) are performing excellently and reaching new highs. The book value per share could rise from USD -0.3171 in 2023 to USD 12.83 in 2027. Possible return on equity in 2027: 11.98%.
Trading strategy: Buy

I am fascinated by the share price potential of Denmark-based Ascendis Pharma A/S (ticker symbol: ASND US): +60.11% since the turn of the year 2024/2025. If everything works out, the operating result (EBIT) could increase from USD -561.8 million to USD 736 million between 2022 and 2027 .Trading strategy: Buy

Yours sincerely,
François Bloch

____

Investment idea of the week

It is important to us to provide you with a concrete investment idea. This week, François Bloch has opted for an implementation with Galderma, Julius Baer and Sulzer pronounced.

A barrier reverse convertible (CH1473747462) on the three shares offers an attractive coupon of 11.05%, with a barrier at 64% and a term of 12 months as a stabilizer in any portfolio.

____

Today at 17:00 it’s that time again: “Bloch live”!

You can look forward to a lively discussion between two experts, exciting topics and honest opinions. Be part of it!

____

Disclaimer
payoff Media AG and François Bloch receive neither payments nor commissions from the products mentioned.